Chapter/Section Purchase

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Benzimidazole
1.2.3 Pyrantel
1.2.4 Piperazine Citrate
1.2.5 Others
1.3 Market by Application
1.3.1 Global Helminthic Infestations Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Enterobius vermicularis
1.3.3 Taenia saginata
1.3.4 Ascaris lumbricoides
1.3.5 Trichuris trichiura
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Helminthic Infestations Therapeutics Market Perspective (2017-2028)
2.2 Helminthic Infestations Therapeutics Growth Trends by Region
2.2.1 Helminthic Infestations Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Helminthic Infestations Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Helminthic Infestations Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Helminthic Infestations Therapeutics Market Dynamics
2.3.1 Helminthic Infestations Therapeutics Industry Trends
2.3.2 Helminthic Infestations Therapeutics Market Drivers
2.3.3 Helminthic Infestations Therapeutics Market Challenges
2.3.4 Helminthic Infestations Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Helminthic Infestations Therapeutics Players by Revenue
3.1.1 Global Top Helminthic Infestations Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Helminthic Infestations Therapeutics Revenue
3.4 Global Helminthic Infestations Therapeutics Market Concentration Ratio
3.4.1 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2021
3.5 Helminthic Infestations Therapeutics Key Players Head office and Area Served
3.6 Key Players Helminthic Infestations Therapeutics Product Solution and Service
3.7 Date of Enter into Helminthic Infestations Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Helminthic Infestations Therapeutics Breakdown Data by Type
4.1 Global Helminthic Infestations Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2023-2028)
5 Helminthic Infestations Therapeutics Breakdown Data by Application
5.1 Global Helminthic Infestations Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Helminthic Infestations Therapeutics Market Size (2017-2028)
6.2 North America Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
6.3 North America Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Helminthic Infestations Therapeutics Market Size (2017-2028)
7.2 Europe Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
7.3 Europe Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Helminthic Infestations Therapeutics Market Size (2017-2028)
9.2 Latin America Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Neural Analytics, Inc.
11.1.1 Neural Analytics, Inc. Company Detail
11.1.2 Neural Analytics, Inc. Business Overview
11.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Introduction
11.1.4 Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.1.5 Neural Analytics, Inc. Recent Development
11.2 M3 Biotechnology, Inc.
11.2.1 M3 Biotechnology, Inc. Company Detail
11.2.2 M3 Biotechnology, Inc. Business Overview
11.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Introduction
11.2.4 M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.2.5 M3 Biotechnology, Inc. Recent Development
11.3 Cerevance
11.3.1 Cerevance Company Detail
11.3.2 Cerevance Business Overview
11.3.3 Cerevance Helminthic Infestations Therapeutics Introduction
11.3.4 Cerevance Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.3.5 Cerevance Recent Development
11.4 Mitochon Pharmaceuticals, Inc.
11.4.1 Mitochon Pharmaceuticals, Inc. Company Detail
11.4.2 Mitochon Pharmaceuticals, Inc. Business Overview
11.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Introduction
11.4.4 Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.4.5 Mitochon Pharmaceuticals, Inc. Recent Development
11.5 Peptilogics
11.5.1 Peptilogics Company Detail
11.5.2 Peptilogics Business Overview
11.5.3 Peptilogics Helminthic Infestations Therapeutics Introduction
11.5.4 Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.5.5 Peptilogics Recent Development
11.6 Farmoquimica S/A
11.6.1 Farmoquimica S/A Company Detail
11.6.2 Farmoquimica S/A Business Overview
11.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Introduction
11.6.4 Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.6.5 Farmoquimica S/A Recent Development
11.7 biOasis Technologies, Inc.
11.7.1 biOasis Technologies, Inc. Company Detail
11.7.2 biOasis Technologies, Inc. Business Overview
11.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Introduction
11.7.4 biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.7.5 biOasis Technologies, Inc. Recent Development
11.8 HCA Healthcare, Inc.
11.8.1 HCA Healthcare, Inc. Company Detail
11.8.2 HCA Healthcare, Inc. Business Overview
11.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Introduction
11.8.4 HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.8.5 HCA Healthcare, Inc. Recent Development
11.9 Alzeca Biosciences, Inc.
11.9.1 Alzeca Biosciences, Inc. Company Detail
11.9.2 Alzeca Biosciences, Inc. Business Overview
11.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Introduction
11.9.4 Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.9.5 Alzeca Biosciences, Inc. Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2017-2022)
11.10.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details